Development of Novel 3-Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer’s Disease
- DOI
- 10.1021/acsomega.5c09187
- Published
- 2025-11-30
- Container
- ACS Omega
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acsomega.5c09187,
title = {Development of Novel 3-Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer’s Disease},
author = {Haibo Wu and Na Huang and Keren Wang and Jing Mi and Zhengwei Liu and Jianta Wang and Zhipei Sang and Zhenghuai Tan},
year = {2025},
journal = {ACS Omega},
doi = {10.1021/acsomega.5c09187},
url = {https://doi.org/10.1021/acsomega.5c09187}
}RIS
TY - JOUR TI - Development of Novel 3-Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer’s Disease AU - Haibo Wu AU - Na Huang AU - Keren Wang AU - Jing Mi AU - Zhengwei Liu AU - Jianta Wang AU - Zhipei Sang AU - Zhenghuai Tan PY - 2025 JO - ACS Omega DO - 10.1021/acsomega.5c09187 UR - https://doi.org/10.1021/acsomega.5c09187 ER -
APA
Wu, H., Huang, N., Wang, K., Mi, J., Liu, Z., Wang, J., Sang, Z., & Tan, Z. (2025). Development of Novel 3-Phenylpropanamide Derivatives as BChE Inhibitors for the Treatment of Alzheimer’s Disease. ACS Omega. https://doi.org/10.1021/acsomega.5c09187
Source records
- crossref · retrieved 2026-09-27T05:55:58.926Z